Swine producers and veterinarians now have access to a new antimicrobial solution to combat swine respiratory disease (SRD) with the launch of Pradalex® (pradofloxacin injection). This FDA-approved injectable antimicrobial, developed by Elanco Animal Health, is designed to provide rapid and targeted treatment against key bacterial pathogens affecting pig health and farm productivity.
A New Approach to Managing Swine Respiratory Disease
Swine respiratory disease remains a major challenge for pork producers, impacting herd health, growth performance, and overall profitability. Pradalex is specifically indicated for the treatment of SRD associated with:
- Bordetella bronchiseptica
- Glaesserella (Haemophilus) parasuis
- Pasteurella multocida
- Streptococcus suis
- Mycoplasma hyopneumoniae
As a broad-spectrum fluoroquinolone antimicrobial, Pradalex provides fast-acting, single-dose treatment that helps producers and veterinarians manage disease outbreaks efficiently.
Pradalex: Targeted Treatment with a Short Withdrawal Period
Administered via intramuscular injection in the neck, Pradalex is formulated to ensure effective bacterial control with precise dosing. The recommended dosage is 7.5 mg/kg (1.7 mL per 100 lbs of body weight), offering a streamlined approach to SRD management.
One of the key advantages of Pradalex is its short withdrawal period—just 2 days for swine intended for human consumption. This ensures that producers can maintain operational flexibility while meeting food safety and regulatory requirements.
Responsible Antibiotic Use & Veterinary Oversight
With a growing focus on antimicrobial stewardship, Pradalex is intended for use only when alternative, non-fluoroquinolone treatments are not suitable. It is not recommended for breeding swine or nursing piglets, aligning with best practices for responsible antibiotic use in modern pork production.
To maintain veterinary oversight, Pradalex is available by prescription only, reinforcing the importance of strategic disease management in commercial swine herds.
What This Means for Swine Producers
For producers seeking an effective solution for managing respiratory disease outbreaks, Pradalex provides a new level of precision and flexibility. With its single-dose treatment, broad bacterial coverage, and short withdrawal period, the product is positioned as an important tool in maintaining herd health and performance.
Swine Web will continue to track new advancements in swine health and provide updates on innovative solutions for producers.
📄 For more information on Pradalex, visit: Elanco Animal Health
📄 Official Press Release & Product Spec Sheet: Pradalex Product Availability
